Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002800978 | SCV003029389 | uncertain significance | Familial aplasia of the vermis | 2022-08-09 | criteria provided, single submitter | clinical testing | This sequence change replaces aspartic acid, which is acidic and polar, with alanine, which is neutral and non-polar, at codon 291 of the AHI1 protein (p.Asp291Ala). This variant is present in population databases (rs760645720, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with AHI1-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt AHI1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002800977 | SCV003577164 | uncertain significance | Inborn genetic diseases | 2022-04-27 | criteria provided, single submitter | clinical testing | The c.872A>C (p.D291A) alteration is located in exon 7 (coding exon 5) of the AHI1 gene. This alteration results from a A to C substitution at nucleotide position 872, causing the aspartic acid (D) at amino acid position 291 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |